Literature DB >> 21471321

Characterization of the effect of heat on agent strains of the transmissible spongiform encephalopathies.

Robert A Somerville1, Nicola Gentles1.   

Abstract

The causal agents of the transmissible spongiform encephalopathy (TSE) diseases, sometimes called prion diseases, are characterized by high resistance to inactivation with heat. Results from thermal inactivation experiments on nine TSE strains, seven passaged in two PrP genotypes, showed differences in sensitivity to heat inactivation ranging over 17 °C. In addition, the rate of inactivation with increasing temperature varied between TSE models. In some cases passage in an alternative PrP genotype had little effect on the resulting inactivation properties, but for others the infectious agent was inactivated at lower temperatures. No strain with higher thermostability properties was selected. The effect of mixing two TSE strains, to see whether their properties were affected through interaction with each other, was also examined. The results showed that both strains behaved as expected from the behaviour of the unmixed controls, and that the strain responsible for inducing TSE disease could be identified. There was no evidence of a direct effect on intrinsic strain properties. Overall, the results illustrate the diversity in properties of TSE strains. They require intrinsic molecular properties of TSE agents to accommodate high resistance to inactivation and a mechanism, independent of the host, to directly encode these differences. These findings are more readily reconciled with models of TSE agents with two separate components, one of which is independent of the host and comprises a TSE-specific nucleic acid, than with models based solely on conformational changes to a host protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471321     DOI: 10.1099/vir.0.030452-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Peroxymonosulfate Rapidly Inactivates the Disease-Associated Prion Protein.

Authors:  Alexandra R Chesney; Clarissa J Booth; Christopher B Lietz; Lingjun Li; Joel A Pedersen
Journal:  Environ Sci Technol       Date:  2016-06-20       Impact factor: 9.028

2.  High CJD infectivity remains after prion protein is destroyed.

Authors:  Kohtaro Miyazawa; Kaitlin Emmerling; Laura Manuelidis
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

Review 3.  How independent are TSE agents from their hosts?

Authors:  Robert A Somerville
Journal:  Prion       Date:  2013-06-18       Impact factor: 3.931

Review 4.  Environmental and host factors that contribute to prion strain evolution.

Authors:  Jason C Bartz
Journal:  Acta Neuropathol       Date:  2021-04-25       Impact factor: 17.088

5.  Structural effects of the highly protective V127 polymorphism on human prion protein.

Authors:  Laszlo L P Hosszu; Rebecca Conners; Daljit Sangar; Mark Batchelor; Elizabeth B Sawyer; Stuart Fisher; Matthew J Cliff; Andrea M Hounslow; Katherine McAuley; R Leo Brady; Graham S Jackson; Jan Bieschke; Jonathan P Waltho; John Collinge
Journal:  Commun Biol       Date:  2020-07-29

6.  Stability of BSE infectivity towards heat treatment even after proteolytic removal of prion protein.

Authors:  Jan P M Langeveld; Anne Balkema-Buschmann; Dieter Becher; Achim Thomzig; Romolo Nonno; Olivier Andréoletti; Aart Davidse; Michele A Di Bari; Laura Pirisinu; Umberto Agrimi; Martin H Groschup; Michael Beekes; Jason Shih
Journal:  Vet Res       Date:  2021-04-16       Impact factor: 3.683

7.  Ex vivo mammalian prions are formed of paired double helical prion protein fibrils.

Authors:  Cassandra Terry; Adam Wenborn; Nathalie Gros; Jessica Sells; Susan Joiner; Laszlo L P Hosszu; M Howard Tattum; Silvia Panico; Daniel K Clare; John Collinge; Helen R Saibil; Jonathan D F Wadsworth
Journal:  Open Biol       Date:  2016-05-04       Impact factor: 6.411

8.  Assessing the aggregated probability of entry of a novel prion disease agent into the United Kingdom.

Authors:  Verity Horigan; Paul Gale; Amie Adkin; Timm Konold; Claire Cassar; John Spiropoulos; Louise Kelly
Journal:  Microb Risk Anal       Date:  2020-08-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.